Spray-on gene therapy for recessive dystrophic epidermolysis bullosa: pre-clinical studies of lentiviral-mediated COL7A1-supplemented epidermal stem cell and CD39+CD26-fibroblast spray-on therapy

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/201915/11/2022

Funding

  • DEBRA UK: £24,955.00
  • DEBRA UK: £174,022.66